Skip to main content
NCBI home page
Gut logoLink to Gut
. 1992 Oct;33(10):1376–1380. doi: 10.1136/gut.33.10.1376

Sclerosing cholangitis and biliary tract calculi--primary or secondary?

C S Pokorny 1, G W McCaughan 1, N D Gallagher 1, W S Selby 1
PMCID: PMC1379607  PMID: 1446863

Abstract

The clinical features of 61 patients with sclerosing cholangitis were reviewed. This group included 23 patients with biliary tract calculi, commonly considered as excluding the diagnosis of primary sclerosing cholangitis. The aim of this study was to compare these 23 patients (group A) with 38 patients with sclerosing cholangitis free of calculi (group B). Both groups had the following features in common: (i) age at presentation, (ii) incidence of inflammatory bowel disease, (iii) extent of radiological disease, (iv) prevalence of HLA-B8 and DR3 haplotype, (v) incidence of cholangiocarcinoma, and (vi) progression to hepatic transplantation (mean follow up 49.9 months). All patients in group A were symptomatic at diagnosis compared with 23 of the 38 patients (61%) in group B. Recurrent ascending cholangitis occurred in 12 patients in group A (52%) and two patients (5%) in group B. The similarity between the two groups was maintained when the nine patients in group A who developed calculi after sclerosing cholangitis was diagnosed were excluded. It is concluded that choledocholithiasis is part of the spectrum of primary sclerosing cholangitis and that it is not necessary to invoke choledocholithiasis as the initial lesion of the bile ducts in such patients.

Full text

PDF
1376

Images in this article

1377Figure 1
on p.1377
1378Figure 2
on p.1378

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen B., Shapiro H., Way L. W. Management of recurrent and residual common duct stones. Am J Surg. 1981 Jul;142(1):41–47. doi: 10.1016/s0002-9610(81)80009-8. [DOI] [PubMed] [Google Scholar]
  2. Bainton D., Davies G. T., Evans K. T., Gravelle I. H. Gallbladder disease. Prevalence in a South Wales industrial town. N Engl J Med. 1976 May 20;294(21):1147–1149. doi: 10.1056/NEJM197605202942103. [DOI] [PubMed] [Google Scholar]
  3. Barker D. J., Gardner M. J., Power C., Hutt M. S. Prevalence of gall stones at necropsy in nine British towns: a collaborative study. Br Med J. 1979 Dec 1;2(6202):1389–1392. doi: 10.1136/bmj.2.6202.1389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cetta F. M. Bile infection documented as initial event in the pathogenesis of brown pigment biliary stones. Hepatology. 1986 May-Jun;6(3):482–489. doi: 10.1002/hep.1840060327. [DOI] [PubMed] [Google Scholar]
  5. Chapman R. W., Arborgh B. A., Rhodes J. M., Summerfield J. A., Dick R., Scheuer P. J., Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980 Oct;21(10):870–877. doi: 10.1136/gut.21.10.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chapman R. W. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis. 1991 Feb;11(1):1–4. doi: 10.1055/s-2008-1040415. [DOI] [PubMed] [Google Scholar]
  7. Chapman R. W., Varghese Z., Gaul R., Patel G., Kokinon N., Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut. 1983 Jan;24(1):38–41. doi: 10.1136/gut.24.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chazouillères O., Poupon R., Capron J. P., Metman E. H., Dhumeaux D., Amouretti M., Couzigou P., Labayle D., Trinchet J. C. Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol. 1990 Jul;11(1):120–123. doi: 10.1016/0168-8278(90)90281-u. [DOI] [PubMed] [Google Scholar]
  9. Duerr R. H., Targan S. R., Landers C. J., LaRusso N. F., Lindsay K. L., Wiesner R. H., Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1991 May;100(5 Pt 1):1385–1391. [PubMed] [Google Scholar]
  10. EDHOLM P., JONSSON G. Bile duct stones related to age and duct width. Acta Chir Scand. 1962 Jul;124:75–79. [PubMed] [Google Scholar]
  11. Farrant J. M., Hayllar K. M., Wilkinson M. L., Karani J., Portmann B. C., Westaby D., Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 1991 Jun;100(6):1710–1717. doi: 10.1016/0016-5085(91)90673-9. [DOI] [PubMed] [Google Scholar]
  12. Friedman G. D., Kannel W. B., Dawber T. R. The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis. 1966 Mar;19(3):273–292. doi: 10.1016/0021-9681(66)90132-9. [DOI] [PubMed] [Google Scholar]
  13. Girard R. M., Legros G. Retained and recurrent bile duct stones. Surgical or nonsurgical removal? Ann Surg. 1981 Feb;193(2):150–154. doi: 10.1097/00000658-198102000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hamilton I., Soutar J. S., Bouchier I. A., Cuschieri A. Short-term biliary dilatation and stenting in primary sclerosing cholangitis. J Clin Gastroenterol. 1987 Feb;9(1):70–75. doi: 10.1097/00004836-198702000-00018. [DOI] [PubMed] [Google Scholar]
  15. Helzberg J. H., Petersen J. M., Boyer J. L. Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology. 1987 Jun;92(6):1869–1875. doi: 10.1016/0016-5085(87)90618-4. [DOI] [PubMed] [Google Scholar]
  16. Jeffrey G. P., Reed W. D., Laurence B. H., Shilkin K. B. Primary sclerosing cholangitis: clinical and immunopathological review of 21 cases. J Gastroenterol Hepatol. 1990 Mar-Apr;5(2):135–140. doi: 10.1111/j.1440-1746.1990.tb01818.x. [DOI] [PubMed] [Google Scholar]
  17. Johnson G. K., Geenen J. E., Venu R. P., Schmalz M. J., Hogan W. J. Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment. Gastrointest Endosc. 1991 Jan-Feb;37(1):38–43. doi: 10.1016/s0016-5107(91)70618-4. [DOI] [PubMed] [Google Scholar]
  18. LaRusso N. F., Wiesner R. H., Ludwig J., MacCarty R. L. Current concepts. Primary sclerosing cholangitis. N Engl J Med. 1984 Apr 5;310(14):899–903. doi: 10.1056/NEJM198404053101407. [DOI] [PubMed] [Google Scholar]
  19. Martin F. M., Rossi R. L., Nugent F. W., Scholz F. J., Jenkins R. L., Lewis W. D., Gagner M., Foley E., Braasch J. W. Surgical aspects of sclerosing cholangitis. Results in 178 patients. Ann Surg. 1990 Oct;212(4):551–558. doi: 10.1097/00000658-199010000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Porayko M. K., Wiesner R. H., LaRusso N. F., Ludwig J., MacCarty R. L., Steiner B. L., Twomey C. K., Zinsmeister A. R. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology. 1990 Jun;98(6):1594–1602. doi: 10.1016/0016-5085(90)91096-o. [DOI] [PubMed] [Google Scholar]
  21. Schrumpf E., Fausa O., Førre O., Dobloug J. H., Ritland S., Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol. 1982 Mar;17(2):187–191. doi: 10.3109/00365528209182038. [DOI] [PubMed] [Google Scholar]
  22. Vartdal F., Gaudernack G., Funderud S., Bratlie A., Lea T., Ugelstad J., Thorsby E. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Tissue Antigens. 1986 Nov;28(5):301–312. doi: 10.1111/j.1399-0039.1986.tb00500.x. [DOI] [PubMed] [Google Scholar]
  23. Wiesner R. H., LaRusso N. F., Ludwig J., Dickson E. R. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology. 1985 Jan;88(1 Pt 1):108–114. doi: 10.1016/s0016-5085(85)80141-4. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES